DENTSPLY SIRONA: Strong Growth and Efficiency Gains Signal Outperform Rating
TipRanks (Thu, 18-Apr 9:15 AM ET)
Needham sees BSX, CNMD, RMD beating Street, despite medtech slow down
Seeking Alpha News (Sun, 14-Apr 5:56 PM ET)
Dentsply Sirona to Host First Quarter Conference Call on May 2nd
Globe Newswire (Tue, 9-Apr 4:30 PM ET)
Business Wire (Tue, 2-Apr 5:35 PM ET)
PRNewswire (Wed, 27-Mar 6:12 PM ET)
Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors
Globe Newswire (Thu, 29-Feb 6:30 AM ET)
Globe Newswire (Thu, 29-Feb 6:00 AM ET)
Dentsply Sirona to Host Fourth Quarter and Full Year 2023 Conference Call on February 29th
Globe Newswire (Mon, 29-Jan 4:15 PM ET)
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).
Dentsply Sirona trades on the NASDAQ stock market under the symbol XRAY.
As of April 19, 2024, XRAY stock price climbed to $30.50 with 1,718,806 million shares trading.
XRAY has a beta of 0.76, meaning it tends to be less sensitive to market movements. XRAY has a correlation of 0.13 to the broad based SPY ETF.
XRAY has a market cap of $6.55 billion. This is considered a Mid Cap stock.
Last quarter Dentsply Sirona reported $1 billion in Revenue and $.44 earnings per share. This beat revenue expectation by $38 million and exceeded earnings estimates by $.01.
In the last 3 years, XRAY stock traded as high as $69.54 and as low as $26.27.
The top ETF exchange traded funds that XRAY belongs to (by Net Assets): VTI, IJH, VB, VOO, VBR.
XRAY has underperformed the market in the last year with a price return of -23.4% while the SPY ETF gained +21.2%. XRAY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -14.6% and -4.4%, respectively, while the SPY returned +4.3% and -3.5%, respectively.
XRAY support price is $29.88 and resistance is $31.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XRAY stock will trade within this expected range on the day.